Mesenchymal Stromal Cells for Acute Graft Versus Host Disease

Summary

A randomised study of corticosteroid therapy with or without mesenchymal stromal cell therapy for newly diagnosed acute graft versus host disease after bone marrow transplantation or donor lymphocyte therapy. It is hypothesised that mesenchymal stromal cell therapy will be superior

Timeline

Start

2012-04

Primary completion

2015-12

Completion

2016-12

Drugs

Indications